| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/24/2003 | US20030077294 Proteinaceous material associated with adenylate cyclase activity in cultures of Bordetella pertussis; useful as components of acellular whooping cough vaccines |
| 04/24/2003 | US20030077291 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077257 Administering a dosage of alive larva of nematodes; immunogens treating cancer of the first and second stages, and AIDS-infections |
| 04/24/2003 | US20030077251 Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins |
| 04/24/2003 | US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer |
| 04/24/2003 | US20030077247 Chemokines as adjuvants of immune response |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | US20030077243 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 04/24/2003 | US20030077232 Oral alkyl hydroxybenzoate; antimicrobial agents |
| 04/24/2003 | US20030077228 Polar solvent 30-99.69%, active compound 0.001-60%, and f lavoring agent 0.1-10%; propellant free |
| 04/24/2003 | US20030077227 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/24/2003 | US20030075172 Method and apparatus for dispensing inhalator medicament |
| 04/24/2003 | CA2727642A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2722197A1 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 04/24/2003 | CA2684419A1 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | CA2466082A1 Anti-microbial composition comprising a metal ion chelating agent |
| 04/24/2003 | CA2463996A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 04/24/2003 | CA2463991A1 Therapeutic composition and use |
| 04/24/2003 | CA2463754A1 Concomitant oral and topical administration of anti - infective agents |
| 04/24/2003 | CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | CA2463711A1 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | CA2463674A1 Controlled release capsules for providing both pulsed burst and controlled release of drugs to the rumen of ruminant animals over an extended time period |
| 04/24/2003 | CA2463655A1 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 04/24/2003 | CA2463641A1 Antisense antiviral agent and method for treating ssrna viral infection |
| 04/24/2003 | CA2463571A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | CA2463016A1 Composition comprising paracetamol and a bitterness masking component |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | CA2461758A1 Use of cystathionine |
| 04/24/2003 | CA2461575A1 Use of peptide vectors to improve the immune response to antigens |
| 04/24/2003 | CA2461542A1 Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| 04/24/2003 | CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | CA2460132A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 04/24/2003 | CA2459572A1 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 04/24/2003 | CA2454578A1 Modified human thymic stromal lymphopoietin |
| 04/23/2003 | EP1304379A2 Humanised antibody against CD18 |
| 04/23/2003 | EP1304346A2 Conjugate of polyethylene glycol and chitosan |
| 04/23/2003 | EP1304118A2 Therapeutic uses and formulations for BPI protein products. |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303632A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 04/23/2003 | EP1303631A2 Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes |
| 04/23/2003 | EP1303625A2 Alpha-msh related compounds and methods of use |
| 04/23/2003 | EP1303613A2 Rescue of canine distemper virus from cdna |
| 04/23/2003 | EP1303612A2 Streptococcus antigens |
| 04/23/2003 | EP1303608A2 Zinc finger domain recognition code and uses thereof |
| 04/23/2003 | EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 04/23/2003 | EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 04/23/2003 | EP1303541A1 Gel compositions containing metronidazole |
| 04/23/2003 | EP1303537A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 04/23/2003 | EP1303523A1 Process for the preparation of the highly pure crystalline (r, s) - cefuroxime axetil |
| 04/23/2003 | EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 04/23/2003 | EP1303520A1 Therapeutic compounds and methods |
| 04/23/2003 | EP1303517A1 Indoloquinazolinones |
| 04/23/2003 | EP1303515A2 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 04/23/2003 | EP1303512A1 Process for preparing arylacetylaminothiazoles |
| 04/23/2003 | EP1303511A1 Oxazolidinone derivatives as antimicrobials |
| 04/23/2003 | EP1303507A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303506A1 6-heteroarylphenanthridines |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303487A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303479A2 7-, 8- and 9-substituted tetracycline compounds |
| 04/23/2003 | EP1303302A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 04/23/2003 | EP1303300A1 Compositions and methods for treatment of candidiasis |
| 04/23/2003 | EP1303295A1 Agent for inhibiting adhesion of the pathogenic flora of the skin |
| 04/23/2003 | EP1303292A1 Chemokine conjugates |
| 04/23/2003 | EP1303291A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 04/23/2003 | EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/23/2003 | EP1303284A1 Compositions and methods for the treatment of skin damage |
| 04/23/2003 | EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 04/23/2003 | EP1303265A2 Use of cox-2 inhibitors for preventing immunodeficiency |
| 04/23/2003 | EP1303262A2 Use of a spla2 inhibitor for the treatment of sepsis |
| 04/23/2003 | EP1303261A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 04/23/2003 | EP1303249A1 Antimycotic nail varnish composition |
| 04/23/2003 | EP1254131A4 Extraction of flavonoids |
| 04/23/2003 | EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/23/2003 | EP1178820A4 Methods of modulating fabh activity |
| 04/23/2003 | EP1175428B1 3-deoxy-desmycosin derivatives and process for their preparation |
| 04/23/2003 | EP1094807B1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 04/23/2003 | EP1077975B1 Water soluble azoles as broad-spectrum antifungals |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | EP1028962B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/23/2003 | EP1027359B1 Monocyclic l-nucleosides, analogs and uses thereof |
| 04/23/2003 | EP1020474B1 Oligosaccharide derivatives and process for producing the same |
| 04/23/2003 | EP1007032B1 4-cyano-4-deformylsordaricin derivatives |
| 04/23/2003 | EP0984975B1 Multicyclic erythromycin derivatives |
| 04/23/2003 | EP0937083B1 A crystalline substance of cefditoren pivoxil and the production of the same |
| 04/23/2003 | EP0889881B1 New triazoles as therapeutic agents for fungal infections |
| 04/23/2003 | EP0873315B1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/23/2003 | EP0871654B1 Protegrins |
| 04/23/2003 | EP0844999B1 Purification process |
| 04/23/2003 | EP0831898B1 Modified meningococcal polysaccharide conjugate vaccines |
| 04/23/2003 | EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/23/2003 | EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody |